IL SB3109

Allows optometrists to prescribe Schedule II controlled substance Dihydrocodeinone (Hydrocodone) combined with one or more non-narcotic ingredients in quantities sufficient for up to 72 hours of treatment, contingent on federal reclassification of such formulations as Schedule II.

Maintains prohibition on optometrists prescribing other Schedule II controlled substances while permitting Schedule III, IV, and V analgesic agents only in quantities sufficient for up to 72 hours of treatment.

Authorizes the Illinois Optometric Board to recommend additional FDA-approved pharmaceutical agents for optometrist use after considering systemic effects and side effects, with the Department required to promulgate rules within 45 days of Board recommendation.

Restricts optometrists' use of injected ocular pharmaceutical agents to anaphylaxis treatment only and requires consultation with a physician for prescribing oral pharmaceuticals to children under 5 years of age.

Amends the Illinois Controlled Substances Act to update definitions and references related to controlled substance prescribing authority by optometrists and other practitioners.